Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $18.5000 (-6.71%) ($18.3000 - $20.4900) on Wed. Apr. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.66% (three month average) | RSI | 56 | Latest Price | $18.5000(-6.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.3% a day on average for past five trading days. | Weekly Trend | EDIT advances 6.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(62%) ARKG(58%) IWO(57%) XBI(56%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.83% in a week (0% probabilities). VIXM(-30%) VXX(-14%) UUP(-14%) TBT(-4%) UNG(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.83% (StdDev 5.66%) | Hourly BBV | 0 () | Intraday Trend | -5.8% | | | |
|
Resistance Level | $19.97 | 5 Day Moving Average | $19.91(-7.08%) | 10 Day Moving Average | $20.06(-7.78%) | 20 Day Moving Average | $19.97(-7.36%) | To recent high | -43.6% | To recent low | 24.3% | Market Cap | $1.149b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |